IMS Consulting Group (IMSCG) is a major player in the field of
global biotech and pharmaceutical management consulting. With
around 500 consultants, the firm maintains a presence on five
continents and focuses on partnering with clients in the
pharmaceuticals, biotech and other life sciences sectors to help
them make informed decisions. IMSCG has growing teams in the
emerging markets, with strong local experts in Brazil, Shanghai,
Singapore, and truly global project work offering teams broader
exposure.
The company has four main centers of excellence: brand and
commercial strategy, competitive intelligence, pricing and market
access, and strategy and portfolio analysis. Altogether, those
units offer clients end-to-end services, qualitative and
quantitative analysis of existing and emerging market trends and
thorough implementation and execution of those strategies.
A healthy outlook
If the IMS name seems familiar in the life sciences context,
that's probably because IMS Consulting Group is a unit of IMS
Health-one of the best-known providers of information services for
the healthcare industry. Having long offered consulting as a
service, the firm decided in 2011 to create a separate identity for
its management consulting arm-and IMS Consulting Group is the
result.
In addition to partnering with some of the biggest names in
pharmaceuticals and biotech, IMSCG consultants also help non-profit
organizations to work towards their goals in designing and
delivering solutions to some of the most pressing global health
programs. One such example is IMSCG's involvement with the Bill and
Melinda Gates foundation, which the firm advised on a program to
improve access to generic medication.